HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lijie Pan Selected Research

N-methyladenosine

1/2022Mettl3-mediated mRNA m6A modification controls postnatal liver development by modulating the transcription factor Hnf4a.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lijie Pan Research Topics

Disease

4Fibrosis (Cirrhosis)
01/2023 - 01/2021
3Liver Cirrhosis (Hepatic Cirrhosis)
12/2022 - 01/2021
3Neoplasms (Cancer)
01/2022 - 01/2018
2Hypoxia (Hypoxemia)
01/2023 - 01/2022
2Sepsis (Septicemia)
01/2022 - 07/2020
2COVID-19
12/2021 - 01/2021
2Breast Neoplasms (Breast Cancer)
01/2021 - 11/2017
1Reperfusion Injury
12/2023
1Ischemia
12/2023
1Open-Angle Glaucoma (Glaucoma, Open Angle)
12/2023
1Cataract (Cataracts)
02/2023
1Anisometropia
02/2023
1Pterygium
02/2023
1Refractive Errors (Refractive Error)
02/2023
1Corneal Opacity
01/2022
1Margins of Excision
01/2022
1Burns
01/2022
1Eye Diseases (Eye Disease)
01/2022
1Hepatocellular Carcinoma (Hepatoma)
01/2022
1Obesity
01/2022
1Pathologic Processes
01/2022
1Acute Liver Failure (Fulminant Hepatic Failure)
01/2022
1Triple Negative Breast Neoplasms
01/2022
1Corneal Injuries
01/2022
1Uveitis
12/2021
1Thyroid Nodule (Nodule, Thyroid)
01/2021
1Hepatitis
01/2021
1Breast Diseases (Breast Disease)
01/2021
1Wounds and Injuries (Trauma)
01/2021
1Papillary Thyroid Cancer
01/2021
1Massive Hepatic Necrosis
01/2021
1Fistula
05/2020
1Secondary Hyperparathyroidism
05/2018
1Chronic Kidney Failure (Chronic Renal Failure)
05/2018
1Stomach Neoplasms (Stomach Cancer)
01/2018
1Neoplasm Metastasis (Metastasis)
09/2012
1Carcinoma (Carcinomatosis)
09/2012
1Hemolysis
09/2012
1Dengue (Dengue Fever)
09/2012

Drug/Important Bio-Agent (IBA)

3Biomarkers (Surrogate Marker)IBA
12/2023 - 11/2017
2AcriflavineIBA
01/2023 - 01/2022
26-methyladenineIBA
12/2022 - 01/2022
2HydrogelsIBA
01/2022 - 01/2022
2RNA (Ribonucleic Acid)IBA
01/2022 - 01/2021
1Glucose (Dextrose)FDA LinkGeneric
12/2023
1EnzymesIBA
12/2023
1Lactic Acid (Lactate)FDA LinkGeneric
12/2023
1MethyltransferasesIBA
12/2022
1N-methyladenosineIBA
01/2022
1AlkaliesIBA
01/2022
1Carbon Tetrachloride (Tetrachloromethane)IBA
01/2022
1Deoxyribonuclease I (Nickase)IBA
01/2022
1Hemostatics (Antihemorrhagics)IBA
01/2022
1LyasesIBA
01/2022
1NADP (NADPH)IBA
01/2022
1PolymersIBA
01/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022
1COVID-19 VaccinesIBA
12/2021
1SteroidsIBA
12/2021
1antigen CYFRA21.1IBA
01/2021
1NestinIBA
01/2021
1CaveolinsIBA
01/2021
1Chitinase-3-Like Protein 1IBA
01/2021
1Concanavalin AIBA
01/2021
1Tumor Biomarkers (Tumor Markers)IBA
01/2021
1VaccinesIBA
01/2021
1LipopolysaccharidesIBA
07/2020
1Therapeutic UsesIBA
05/2018
1LipidsIBA
11/2017
1Proline (L-Proline)FDA Link
11/2017
1Drug CarriersIBA
09/2012
1MicellesIBA
09/2012
1AntibodiesIBA
09/2012

Therapy/Procedure

4Therapeutics
01/2022 - 01/2018
2Topical Administration
01/2023 - 01/2022
2Injections
01/2022 - 01/2022
2Transplantation
01/2022 - 01/2022
1Slit Lamp
02/2023
1Immunotherapy
01/2022
1Parathyroidectomy
05/2018
1Renal Dialysis (Hemodialysis)
05/2018